title: [The use of ethaden in the complex treatment of newly diagnosed patients with infiltrative tuberculosis of the lungs].
abstract: As a means of the tuberculosis pathogenetic therapy, the authors recommend the use of ethaden belonging to a purine derivative group. Forty two newly discovered cases with infiltrative pulmonary tuberculosis in the cavitation phase were subjected to the treatment. Positive outcomes were obtained, as confirmed by clinico-roentgenologic data and lymphocyte functional activity estimate. Higher rates of cavity healing were achieved.
authors.forename: B S
authors.initials: BS
authors.lastname: Kibrik
authors.forename: G O
authors.initials: GO
authors.lastname: Krylova
mesh_terms: D000225:Adenine / Q000031:analogs & derivatives* / Q000627:therapeutic use; D000328:Adult; D000995:Antitubercular Agents / Q000627:therapeutic use*; D006801:Humans; D008297:Male; D008875:Middle Aged; D014397:Tuberculosis, Pulmonary / Q000188:drug therapy*
chemical_list: D000995:Antitubercular Agents; C014531:etaden; D000225:Adenine
vernacular_title: Primenenie étadena v kompleksnom lechenii vpervye vyiavlennykh bol'nykh infil'trativnym tuberkulezom legkikh.